By Todd Andrews, Director of Application and Business Development, Colder Products Company
Considering the inherent complexity of biologic development and manufacturing and the added business pressures of biopharma’s challenging landscape, the margin for error in today’s industry is small. That is why minimizing the threat of contamination using a closed system during drug development and manufacturing is critical. Yet, the traditional method for connecting each step in a closed process may present other risks to the integrity of your product. Therefore, it is important you have confidence that the single-use sterile connectors you select meet the sterility and reliability needs of your particular application.